These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16495579)

  • 1. Structural analysis of the interaction between Shiga toxin B subunits and linear polymers bearing clustered globotriose residues.
    Watanabe M; Igai K; Matsuoka K; Miyagawa A; Watanabe T; Yanoshita R; Samejima Y; Terunuma D; Natori Y; Nishikawa K
    Infect Immun; 2006 Mar; 74(3):1984-8. PubMed ID: 16495579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections.
    Watanabe M; Matsuoka K; Kita E; Igai K; Higashi N; Miyagawa A; Watanabe T; Yanoshita R; Samejima Y; Terunuma D; Natori Y; Nishikawa K
    J Infect Dis; 2004 Feb; 189(3):360-8. PubMed ID: 14745692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinities of Shiga toxins 1 and 2 for univalent and oligovalent Pk-trisaccharide analogs measured by electrospray ionization mass spectrometry.
    Kitova EN; Kitov PI; Paszkiewicz E; Kim J; Mulvey GL; Armstrong GD; Bundle DR; Klassen JS
    Glycobiology; 2007 Oct; 17(10):1127-37. PubMed ID: 17686801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of binding platforms yields insights into receptor binding differences between shiga toxins 1 and 2.
    Flagler MJ; Mahajan SS; Kulkarni AA; Iyer SS; Weiss AA
    Biochemistry; 2010 Mar; 49(8):1649-57. PubMed ID: 20092352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress of Shiga toxin neutralizer for treatment of infections by Shiga toxin-producing Escherichia coli.
    Nishikawa K
    Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):239-47. PubMed ID: 21644029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Gb3/CD77 synthase produces P1 glycotope-capped N-glycans, which mediate Shiga toxin 1 but not Shiga toxin 2 cell entry.
    Szymczak-Kulus K; Weidler S; Bereznicka A; Mikolajczyk K; Kaczmarek R; Bednarz B; Zhang T; Urbaniak A; Olczak M; Park EY; Majorczyk E; Kapczynska K; Lukasiewicz J; Wuhrer M; Unverzagt C; Czerwinski M
    J Biol Chem; 2021; 296():100299. PubMed ID: 33460651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assembly and stability of the shiga toxins investigated by electrospray ionization mass spectrometry.
    Kitova EN; Mulvey GL; Dingle T; Sinelnikov I; Wee S; Griener TP; Armstrong GD; Klassen JS
    Biochemistry; 2009 Jun; 48(23):5365-74. PubMed ID: 19400587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The serine 31 residue of the B subunit of Shiga toxin 2 is essential for secretion in enterohemorrhagic Escherichia coli.
    Shimizu T; Kawakami S; Sato T; Sasaki T; Higashide M; Hamabata T; Ohta T; Noda M
    Infect Immun; 2007 May; 75(5):2189-200. PubMed ID: 17325057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoprophylactic potential of cloned Shiga toxin 2 B subunit.
    Marcato P; Mulvey G; Read RJ; Vander Helm K ; Nation PN; Armstrong GD
    J Infect Dis; 2001 Feb; 183(3):435-43. PubMed ID: 11133375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baicalein Inhibits Stx1 and 2 of EHE: Effects of Baicalein on the Cytotoxicity, Production, and Secretion of Shiga Toxins of Enterohaemorrhagic Escherichia coli.
    Vinh PT; Shinohara Y; Yamada A; Duc HM; Nakayama M; Ozawa T; Sato J; Masuda Y; Honjoh KI; Miyamoto T
    Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31470657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Conserved Structural Motif Mediates Retrograde Trafficking of Shiga Toxin Types 1 and 2.
    Selyunin AS; Mukhopadhyay S
    Traffic; 2015 Dec; 16(12):1270-87. PubMed ID: 26420131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a Shiga-toxin type I variant containing an IS1203-like element, from Shiga-toxin producing Escherichia coli O157:H7.
    Suzuki M; Kondo F; Ito Y; Matsumoto M; Hata M; Oka H; Takahashi M; Sakae K
    FEMS Microbiol Lett; 2004 May; 234(1):63-7. PubMed ID: 15109720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and assessment of globotriose-chitosan conjugate, a novel inhibitor of shiga toxins produced by Escherichia coli.
    Li X; Wu P; Cheng S; Lv X
    J Med Chem; 2012 Mar; 55(6):2702-10. PubMed ID: 22372889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shiga toxin binding to glycolipids and glycans.
    Gallegos KM; Conrady DG; Karve SS; Gunasekera TS; Herr AB; Weiss AA
    PLoS One; 2012; 7(2):e30368. PubMed ID: 22348006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptides derived from phage display libraries as potential neutralizers of Shiga toxin-induced cytotoxicity in vitro and in vivo.
    Bernedo-Navarro RA; Miyachiro MM; da Silva MJ; Reis CF; Conceição RA; Gatti MS; Yano T
    J Appl Microbiol; 2014 May; 116(5):1322-33. PubMed ID: 24447276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shiga toxin-binding site for host cell receptor GPP130 reveals unexpected divergence in toxin-trafficking mechanisms.
    Mukhopadhyay S; Redler B; Linstedt AD
    Mol Biol Cell; 2013 Aug; 24(15):2311-8. PubMed ID: 23761068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escherichia coli serogroup O107/O117 lipopolysaccharide binds and neutralizes Shiga toxin 2.
    Gamage SD; McGannon CM; Weiss AA
    J Bacteriol; 2004 Aug; 186(16):5506-12. PubMed ID: 15292153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shiga-like toxin binds with high avidity to multivalent O-linked blood group P1 determinants on mucin-type fusion proteins.
    Maria Cherian R; Gaunitz S; Nilsson A; Liu J; Karlsson NG; Holgersson J
    Glycobiology; 2014 Jan; 24(1):26-38. PubMed ID: 24082034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do the A subunits contribute to the differences in the toxicity of Shiga toxin 1 and Shiga toxin 2?
    Basu D; Tumer NE
    Toxins (Basel); 2015 Apr; 7(5):1467-85. PubMed ID: 25938272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An entropically efficient supramolecular inhibition strategy for Shiga toxins.
    Kitov PI; Lipinski T; Paszkiewicz E; Solomon D; Sadowska JM; Grant GA; Mulvey GL; Kitova EN; Klassen JS; Armstrong GD; Bundle DR
    Angew Chem Int Ed Engl; 2008; 47(4):672-6. PubMed ID: 18098248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.